Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An update on transfusion-transmitted viruses

N L Luban1

  • 1Transfusion Medicine, Children's Hospital, Washington, DC 20010, USA.

Current Opinion in Pediatrics
|April 8, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting risk of peripartum blood transfusion during vaginal and cesarean delivery: A risk prediction model.

Journal of neonatal-perinatal medicine·2023
Same author

Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components.

Seminars in hematology·2001
Same author

Inflammatory myopathy and hepatitis C in a pediatric patient: role of liver biopsy in evaluating the severity of liver disease.

Hepatology (Baltimore, Md.)·2001
Same author

The transfusion-transmitted viruses in blood transfusion.

Advances in experimental medicine and biology·2001
Same author

Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.

Transfusion·2001
Same author

Low factor VIII recovery in haemophilia A patients without inhibitor titre is not due to the presence of anti-factor VIII antibodies undetectable by the Bethesda assay.

Haemophilia : the official journal of the World Federation of Hemophilia·2001
Same journal

For health, for beauty, or both? navigating trends as adolescent clinicians.

Current opinion in pediatrics·2026
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
See all related articles

Future blood supply may be zero-risk thanks to advanced donor screening. However, current serologic tests and donor questioning still leave residual risks for transfusion-transmitted diseases.

Area of Science:

  • Transfusion Medicine
  • Infectious Disease Control

Background:

  • Blood donor screening has significantly improved safety.
  • The concept of a zero-risk blood supply is an emerging goal.

Purpose of the Study:

  • To review the literature on transfusion-transmitted diseases.
  • To assess residual risks in blood transfusion.

Main Methods:

  • Literature review of transfusion-transmitted diseases.
  • Analysis of current blood donor screening practices.

Main Results:

  • Despite advances, transfusion-transmitted diseases remain a risk.
  • Serologic tests and donor questioning have limitations.

Conclusions:

Related Experiment Videos

  • Achieving a zero-risk blood supply requires ongoing research.
  • Continuous improvement in screening methods is essential.